Arginase activity and nitric oxide levels in patients with obstructive sleep apnea syndrome

Clinics

Volumn 69, Issue 4, 2014, Pages 247-252

  Yüksel, Meral ^a   Okur, Hacer Kuzu ^b   Pelin, Zerrin ^c   Öǧünç, Ayliz Velioǧlu ^a   Öztürk, Levent ^d  

^a MARMARA UNIVERSITY   (Turkey)

^b Fatih Sultan Mehmet Education and Research Hospital   (Turkey)

^c HASAN KALYONCU UNIVERSITY   (Turkey)

^d TRAKYA UNIVERSITY   (Turkey)

Author keywords

Arginase activity; Cardiovascular diseases; Nitric oxide; Obstructive sleep apnea syndrome

Indexed keywords

ARGINASE; ARGININE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE;

ADULT; ANALYSIS OF VARIANCE; ARTICLE; BLOOD; BODY MASS; CARDIOVASCULAR DISEASE; CASE CONTROL STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; ENZYMOLOGY; FEMALE; HUMAN; MALE; METABOLISM; MIDDLE AGED; POLYSOMNOGRAPHY; SLEEP DISORDERED BREATHING;

ADULT; ANALYSIS OF VARIANCE; ARGINASE; ARGININE; BODY MASS INDEX; CARDIOVASCULAR DISEASES; CASE-CONTROL STUDIES; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; MALE; MIDDLE AGED; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; POLYSOMNOGRAPHY; SLEEP APNEA, OBSTRUCTIVE;

EID: 84898765519     PISSN: 18075932     EISSN: None     Source Type: Journal    
DOI: 10.6061/clinics/2014(04)05     Document Type: Article

References (33)

1. McNicholas WT, Bonsignore MR, and Management Committee of EU COST ACTION B26. Sleep apnoea as an independent risk factor for cardiovascular disease: current evidence, basic mechanisms and research priorities. Eur Respir J. 2007;29(1):158-78.
2. Suzuki YJ, Jain V, Park AM, Day RM. Oxidative stress and oxidant signaling in obstructive sleep apnea and associated cardiovascular diseases. Free Radic Biol Med. 2006;40(10):1683-92.
3. Spieker LE, Noll G, Ruschitzka FT, Maier W, Lüscher TF. Working under pressure: the vascular endothelium in arterial hypertension. J Human Hypertens. 2000;14(10-11):617-30.
4. Kaditis A, Alexopoulos E, Ntamagka G, Chaidas K, Karathanasi A, Gougoura S, et al. Serum nitrite and nitrate levels in children with obstructive sleep-disordered breathing. Sleep Med. 2010;11(3):258-62.
5. Teramoto S, Kume H, Matsuse T, Ishii T, Miyashita A, Akishita M, et al. Oxygen administration improves the serum level of nitric oxide metabolites in patients with obstructive sleep apnea syndrome. Sleep Med. 2003;4(5):403-7.
6. Schulz R, Schmidt D, Blum A, Lopes-Ribeiro X, Lücke C, Mayer K, et al. Decreased plasma levels of nitric oxide derivatives in obstructive sleep apnoea: response to CPAP therapy. Thorax. 2000;55(12):1046-51.
7. Ip MSM, Lam B, Chan LY, Zheng L, Tsang KWT, Fung PCW, et al. Circulating nitric oxide is suppressed in obstructive sleep apnea and is reversed by nasal continuous positive airway pressure. Am J Respir Crit Care Med. 2000;162(6):2166-71.
8. Noda A, Nakata S, Koike Y, Miyata S, Kitaichi K, Nishizawa T, et al. Continuous positive airway pressure improves daytime baroreflex sensitivity and nitric oxide production in patients with moderate to severe obstructive sleep apnea syndrome. Hypertens Res. 2007;30(8): 669-76.
9. Ozkan Y, Fi{dotless}rat H, Şimşek B, Torun M, Yardim-Akaydin S. Circulating nitric oxide (NO), asymmetric dimethlarginine (ADMA), homocysteine, and oxidative status in obstructive sleep-apnea-hypopnea syndrome (OSAHS). Sleep Breath. 2008;12(2):149-54.
10. Durante W, Johnson FK, Johnson RA. Arginase: A critical regulator of nitric oxide synthesis and vascular function. Clin Exp Pharmacol Physiol. 2007;34(9):906-11.
11. Munder M. Arginase: an emerging key player in the mammalian immune system. Br J Pharmacol. 2009;158(3):638-51.
12. Bachetti T, Comini L, Francolini G, Bastianon D, Valetti B, Cadei M, et al. Arginase pathway in human endothelial cells in pathophysiological conditions. J Mol Cell Cardiol. 2004;37(2):515-23.
13. Ogino K, Takahashi N, Takigawa T, Obase Y, Wang DH. Association of serum arginase I with oxidative stress in healthy population. Free Radic Res. 2011;45(2):147-55.
14. Getz GS, Reardon CA. Arginine/Arginase NO NO NO. Arterioscler Thromb Vasc Biol. 2006;26(2):237-9.
15. Kent BD, Ryan S, McNicholas WT. Obstructive sleep apnea and inflammation: Relationship to cardiovascular co-morbidity. Respir Physiol Neurobiol. 2011;178(3):475-81.
16. Öztürk L, Mansour B, Yüksel M, Yalçi{dotless}n AS, Çelikoǧlu F, Gökhan N. Lipid peroxidation and osmotic fragility of red blood cells in sleep apnea patient. Clin Chim Acta. 2003;332(1-2):83-8.
17. [No authors listed]. Sleep-related breathing disorders in adults: recommendations for syndrome definition and measurement techniques in clinical research. The Report of an American Academy of Sleep Medicine Task Force. Sleep. 1999;22(5):667-89.
18. Rechtschaffen A, Kales A (1968). A Manual of Standardized Terminology, Technique, and Scoring System for Sleep Stages of Human Subjects, BIS/ BRI, UCLA, Los Angeles.
19. Bekpinar S, Gurdol F, Unlucerci Y, Develi S, Yilmaz A. Serum levels of arginase I are associated with left ventricular function after myocardial infarction. Clin Biochem. 2011;44(13):1090-3.
20. Jung C, Gonon AT, Sjöquist P-O, Lundberg JO, Pernow J. Arginase inhibition mediates cardioprotection during ischaemia-reperfusion. Cardiovasc Res. 2010;85(1):147-54.
21. Thacher TN, Gambrillara V, Riche F, Silacci P, Stergiopulos N, da Silva RF. Regulation of arginase pathway in response to wall shear stress. Atherosclerosis. 2010;210(1):63-70.
22. Romero MJ, Platt DH, Tawfik HE, Labazi M, El-Remessy AB, Bartoli M, et al. Diabetes-induced coronary vascular dysfunction involves increased arginase activity. Circ Res. 2008;102(1):95-102.
23. Ohike Y, Kozaki K, Iijima K, Eto M, Kojima T, Ohga E, et al. Amelioration of vascular endothelial dysfunction in obstructive sleep apnea syndrome by nasal continuous positive airway pressure possible involvement of nitric oxide and asymmetric NG, NG-dimethylarginine. Circ J. 2005;69 (2):221-6.
24. Haight JSJ, Djupesland PG. Nitric oxide (NO) and obstructive sleep apnea (OSA). Sleep Breath. 2003;7(2):53-61.
25. Oyama J, Yamamoto H, Maeda T, Ito A, Node K, Makino N. Continuous positive airway pressure therapy improves vascular dysfunction and decreases oxidative stress in patients with the metabolic syndrome and obstructive sleep apnea syndrome. Clin Cardiol. 2012;35(4):231-6.
26. Yagihara F, Lucchesi LM, D'Almeida V, de Mello MT, Tufik S, Rita L, et al. Oxidative stress and quality of life in elderly patients with obstructive sleep apnea syndrome: are there differences after six months of continuous positive airway pressure treatment? Clinics. 2012;67 (6):565-71.
27. Garvey J, Ryan S, Taylor CT, McNicholasWT. Oxidative stress, inflammation and vascular function in obstructive sleep apnea syndrome. (In): Bradley TD, Floras JS (eds). Sleep apnea: implications in cardiovascular and cerebrovascular disease. 2nd ed. Informa Healthcare, New York 2010, pp:110-122.
28. Carlson JT, Hedner JA, Sellgren J, Elam M, Wallin BG. Depressed baroreflex sensitivity in patients with obstructive sleep apnea. Am J Respir Crit Care Med. 1996;154(5):1490-6.
29. Shamsuzzaman ASM, Winnicki M, Lanfranchi P, Wolk R, Kara T, Accurso V, et al. Elevated C-reactive protein in patients with obstructive sleep apnea. Circulation. 2002;105(21):2462-4.
30. Kokturk O, Ciftci TU, Mollarecep E, Ciftci B. Elevated c-reactive protein levels and increased cardiovascular risk in patients with obstructive sleep apnea syndrome. Int Heart J. 2005;46(5):801-9.
31. Fike CD, Kaplowitz MR, Thomas CJ, Nelin LD. Chronic hypoxia decreases nitric oxide production and endothelial nitric oxide synthase in newborn pig lungs. Am J Physiol. 1998;274(4 Pt 1):L517-6.
32. Suschek CV, Schnorr O, Hemmrich K, Aust O, Klotz L-O, Sies H, Kolb-Bachofen V. Critical role of L-arginine in endothelial cell survival during oxidative stress. Circulation. 2003;107(20):2607-14.
33. Singh U, Devaraj S, Vasquez-Vivar J, Jialal I. C-reactive protein decreases endothelial nitric oxide synthase activity via uncoupling. J Mol Cell Cardiol. 2007;43(6):780-91.